BioLineRx Ltd. Share Price
NASDAQ: BLRXBioLineRx Ltd. Stock Performance
BioLineRx Ltd. Share Price Today
As of 28 October 2026, BioLineRx Ltd.'s share price is $2.06. The stock opened at $2.01, compared to its previous close of $1.98. During today's trading session, BioLineRx Ltd.'s share price traded between $2.00 and $2.01, with an average price of $2.00. Over the past 52 weeks, the stock has recorded a high of $3.88 and a low of $1.96. In terms of performance, BioLineRx Ltd.'s share price has declined by 29.45% over the last six months and is down 41.64% on a year-on-year basis.
BioLineRx Ltd. Share Price Chart
About BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
BioLineRx Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.32 | $2.00 | -20.32% |
Sep 2026 | $2.62 | $2.51 | -8.06% |
Aug 2026 | $2.73 | $2.73 | +0.74% |
Jul 2026 | $3.11 | $2.71 | -12.01% |
Jun 2026 | $3.26 | $3.08 | -20.62% |
May 2026 | $2.95 | $3.88 | +32.88% |
Apr 2026 | $2.20 | $2.92 | +21.67% |
Mar 2026 | $2.81 | $2.40 | -16.38% |
Feb 2026 | $3.07 | $2.87 | -7.42% |
Jan 2026 | $2.81 | $3.10 | +7.27% |
Dec 2025 | $3.32 | $2.89 | -18.59% |
Nov 2025 | $3.43 | $3.55 | +0.57% |